This article which was published in Fibromyalgia News Today on June 18th 2015‘an open-label pilot study’ – ‘The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study‘, which tried out an extended-release form of Gabapentin called G-GR (gastroretentive gabapentin) for the treatment of Fibromyalgia. However, as it is suggested in the article, although it gave some interesting results more in-depth research is required but the article instils a little hope for the development of medicines for Fibromyalgia 🙂
In a new study entitled “The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study” researchers showed that administration of the drug gabapentin (in an extended-release approach), initially prescribed as an anti-epilepsy medication, relieved fibromyalgia-associated pain symptoms and improved fibromyalgia patients’ quality of life. The study was published in the journal Pain Practice.
Read the rest of the article via: Novel Form of Extended-Release Gabapentin Improves Fibromyalgia Patients’ Pain Symptoms and Sleep Disorder Fibromyalgia News Today.